Beta-blocker interruption not noninferior to continuation following myocardial infarction
1. In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy ...
Tag: beta blocker
#VisualAbstract: Beta-Blocker Interruption Resulted in Similar Outcomes to Continuation after Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Beta-blockers do not lower mortality after myocardial infarction with preserved ejection fraction
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality among patients with preserved left ventricular ejection ...
Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease
1. A significant reduction in all-cause mortality was seen among patients in the intervention group compared to usual care. 2. ...
Angiotensin receptor blockers may reduce the incidence of epilepsy in patients with hypertension
1. Amongst a cohort of individuals with arterial hypertension, those who were taking angiotensin receptor blocker antihypertensives had the lowest ...
Antihypertensives reduce the rate of progressive aortic root dilation in Marfan syndrome
1. Compared to control, ARBs reduced the annual rate of increase of the aortic root Z score by approximately one-half. ...
#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
#VisualAbstract: Metoprolol for the Prevention of Acute Exacerbations of COPD
1. In this double-blind randomized trial of COPD patients without previous indication for beta blocker therapy, treatment with extended-release beta-blockers ...